Bristol-Myers Squibb (Portugal)
Bristol-Myers Squibb Portugal is the Portuguese operation of the global biopharmaceutical company, focused on researching, developing and supplying medicines for serious diseases.
Last updated September 25, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Bristol-Myers Squibb (Portugal), also referred to as BMS Portugal, is the Portuguese operation of the global biopharmaceutical company Bristol Myers Squibb. The company identifies its local base as Paço de Arcos, Portugal. Its stated purpose is to help patients overcome serious diseases by discovering, developing and making innovative medicines available to them. In Portugal, the company says it supplies medicines to patients and that its employees focus on helping people overcome serious illnesses. Its local work is presented as part of the wider group’s research-and-development and medicine-supply mission. The Portuguese site also describes responsibility to society and patient communities as part of the company’s work, alongside developing medicines. BMS Portugal operates within a group that its corporate website describes as a global biopharmaceutical company headquartered in New York, with more than 150 years of history, over 30,000 employees and operations in more than 40 countries. The group’s stated vision is to transform patients’ lives through science. Its stated values include integrity, urgency, responsibility, innovation, passion and inclusion. The supplied sources do not identify a local founder, a precise incorporation date, named Portuguese executives or specific medicines marketed by the local operation. The Portuguese homepage highlights the 60th anniversary of BMS Portugal and reports Great Place to Work recognition and Age Friendly employer certification.
History
Bristol-Myers Squibb Portugal is the Portuguese operation of the global Bristol Myers Squibb biopharmaceutical group. The available corporate material situates the local operation within a company whose mission is to discover, develop and make innovative medicines available to patients to help them overcome serious diseases. The group describes itself as global, headquartered in New York, with more than 150 years of history, over 30,000 employees and activity in more than 40 countries. These are group-level details; the supplied material does not provide a founding date or a detailed legal history for the Portuguese entity. The local company’s homepage describes its work as supplying medicines to patients in Portugal and says its employees focus on helping patients overcome serious diseases. It also presents the Portuguese operation as having a history of innovation in service of life and marks a 60th anniversary. The source does not state the anniversary’s calendar year, so a precise local founding year cannot be established from the available evidence. Another homepage statement says BMS Portugal has supplied medicines to patients in Portugal for more than a decade; this describes the duration of supply in that text and does not establish the entity’s incorporation date. BMS Portugal’s stated work combines medicine research, development and supply with attention to patient and community wellbeing. Its public-facing principles are connected to the wider group’s declared values of integrity, urgency, responsibility, innovation, passion and inclusion. The group says its vision is to transform patients’ lives through science and that it seeks to focus on scientific strength, innovative treatments, and care for patients and employees. The Portuguese site also reports Great Place to Work recognition and Age Friendly employer certification, but the supplied material does not give dates for these recognitions. No specific local product launches, acquisitions, leadership changes, listings or named medicines are documented in the supplied sources.
Products and positioning
A science-led biopharmaceutical operation focused on discovering, developing and supplying innovative medicines for patients with serious diseases.
Innovative medicines for serious diseases
The company describes its work as researching, developing and supplying innovative medicines; the supplied sources do not identify individual products.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/bristol-myers-squibb-portugal · Editorial policy · How profiles are compiled